These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 831439)

  • 21. Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease.
    Peters RL; Gay T; Reynolds TB
    Am J Clin Pathol; 1975 Mar; 63(3):318-31. PubMed ID: 46697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Jejunoileal bypass for obesity: liver function and morphology in the postoperative period].
    Beno I; Horváth A; Rozhold J; Príkazská M; Virsík A
    Cesk Gastroenterol Vyz; 1980 Oct; 34(7):439-46. PubMed ID: 7448877
    [No Abstract]   [Full Text] [Related]  

  • 23. Reanastomosis after jejunoileal bypass.
    Halverson JD; Gentry K; Wise L; Ballinger WF
    Surgery; 1978 Aug; 84(2):241-9. PubMed ID: 684615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversibility of severe hepatic damage caused by jejunoileal bypass after re-establishment of normal intestinal continuity.
    Soyer MT; Ceballos R; Aldrete JS
    Surgery; 1976 May; 79(5):601-4. PubMed ID: 1265672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver failure with steatonecrosis after jejunoileal bypass: recovery with parenteral nutriton and reanastomosis.
    Baker AL; Elson CO; Jaspan J; Boyer JL
    Arch Intern Med; 1979 Mar; 139(3):289-92. PubMed ID: 106783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal adaptation and hepatic decompensation after jejunoileal bypass for morbid obesity.
    Nutr Rev; 1977 Feb; 35(2):43-5. PubMed ID: 320510
    [No Abstract]   [Full Text] [Related]  

  • 27. Doxycycline in the prevention of hepatic dysfunction: an evaluation of its use following jejunoileal bypass in humans.
    Yost RL; Duerson MC; Russell WL; O'Leary JP
    Arch Surg; 1979 Aug; 114(8):931-4. PubMed ID: 464807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: The liver after jejunoileal bypass.
    Lancet; 1976 Sep; 2(7987):666-7. PubMed ID: 60523
    [No Abstract]   [Full Text] [Related]  

  • 29. Granulomatous hepatitis associated with jejunoileal bypass surgery.
    Kalat ED; Martin DB
    JAMA; 1981 Aug; 246(9):982. PubMed ID: 7253183
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic effects of jejunoileal bypass for morbid obesity.
    Brown RG; O'Leary JP; Woodward ER
    Am J Surg; 1974 Jan; 127(1):53-8. PubMed ID: 4808687
    [No Abstract]   [Full Text] [Related]  

  • 31. Morbid obesity: good and poor results of jejunoileal and gastric bypass.
    Buckwalter JA
    Am J Clin Nutr; 1980 Feb; 33(2 Suppl):476-80. PubMed ID: 7355822
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic dysfunction following bypass operation.
    Moussavian SN
    JAMA; 1977 Jun; 237(23):2469. PubMed ID: 576952
    [No Abstract]   [Full Text] [Related]  

  • 33. [Parenteral amino acid therapy of liver damage after jejunoileal bypass].
    Brinch L; Blomhoff JP; Skrede S; Foerster A
    Tidsskr Nor Laegeforen; 1983 Aug; 103(23):1644-5. PubMed ID: 6636078
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity.
    Mezey E; Imbembo AL; Potter JJ; Rent KC; Lombardo R; Holt PR
    Am J Clin Nutr; 1975 Nov; 28(11):1277-83. PubMed ID: 1190105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The liver of the severely obese patient treated with a jejuno-ileal shunt. Functional and morphological aspects].
    Scopinaro N; Badini A; Gianetta E; Bonalumi U
    Minerva Chir; 1976 May; 31(10):577-86. PubMed ID: 972734
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of liver failure in a patient following jejunoileal bypass.
    Monroe P; Baker AL; Glagov S; Sitrin M
    Gastroenterology; 1980 Jun; 78(6):1593-601. PubMed ID: 7372075
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic structure and function after modified jejunoileal bypass surgery for obesity.
    Maxwell JD; Sanderson I; Butler WH; Gazet JC; Pilkington TR
    Br Med J; 1977 Sep; 2(6089):726-9. PubMed ID: 912271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of hepatic failure following jejunoileal bypass by a modification of Payne's operation.
    Messaris GE; Mariatos CG; Mazis A; Statherou P
    World J Surg; 1979 Jun; 3(1):111-4, 140-3. PubMed ID: 483831
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic complications of jejunoileal bypass operations for morbid obesity.
    Scott HW; Dean RH; Shull HJ; Gluck FW
    Annu Rev Med; 1976; 27():397-405. PubMed ID: 938008
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liver damage following intestinal by-pass surgery for weight reduction].
    Schmeisser W; Schrader CP; Greim H; von Oldershausen HF
    Z Gastroenterol; 1975 Nov; 13(7):619-28. PubMed ID: 1229212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.